metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Información de la revista
Número
Vol. 13. Núm. 5.
Páginas 480-711 (septiembre - octubre 2014)
Hepatology highlights
Hepatology highlights
Giorgio Bedogni, Claudio Tiribelli
Ann Hepatol. 2014;13:480-1
Open access
Concise review
Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients
Caroline Buss, Cristiane Valle-Tovo, Suellen Miozzo, Angelo Alves de Mattos
Ann Hepatol. 2014;13:482-8
Open access
Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease
Zhang Wenfeng, Wu Yakun, Mu Di, Gong Jianping, Wu Chuanxin, Huang Chun
Ann Hepatol. 2014;13:489-95
Open access
Original article
Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina
María S. Munné, Nancy R. Altabert, Lucio O. Otegui M., Sara N. Vladimirsky, Rita Moreiro, María P. Espul, Carlos Espul, Abelardo Manzur, ... Jorge E. González
Ann Hepatol. 2014;13:496-502
Open access
Treatment of chronic hepatitis C genotype 1 early responders with 36 week pegylated interferon and ribavirin therapy
Ajit Sood, Vandana Midha, Omesh Goyal
Ann Hepatol. 2014;13:503-9
Open access
Hepatitis E virus exposure in pregnant women in rural Durango, Mexico
Cosme Alvarado-Esquivel, Luis F. Sánchez-Anguiano, Jesús Hernández-Tinoco
Ann Hepatol. 2014;13:510-7
Open access
Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?
Abdel-Rahman N. Zekri, Ahmed M. Raafat, Suzan Elmasry, Abeer A. Bahnassy, Yasmin Saad, Hamed A. Dabaon, Mohamed El-Kassas, Hend I. Shousha, ... Nehal Hussein
Ann Hepatol. 2014;13:518-24
Open access
Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience
Nabiha Faisal, Eric M. Yoshida, Marc Bilodeau, Philip Wong, Mang Ma, Kelly W. Burak, Bandar Al-Judaibi, Eberhard L. Renner, Leslie B. Lilly
Ann Hepatol. 2014;13:525-32
Open access
Survey of health status, nutrition and geography of food selection of chronic liver disease patients
Timothy Leslie, Lisa Pawloski, Jillian Kallman-Price, Carey Escheik, Noreen Hossain, Yun Fang, Lynn H. Gerber, Zobair M. Younossi
Ann Hepatol. 2014;13:533-40
Open access
Ultra-sensitive procalcitonin may help rule out bacterial infections in patients with cirrhosis
Sebastián Marciano, Leila Haddad, Alfredo P. Martínez, María L. Posadas, Federico Piñero, Gonzalo J. Mora, Laura N. Guerrero, Ezequiel Ridruejo, ... Adrián C. Gadano
Ann Hepatol. 2014;13:541-7
Open access
Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes
Karlyn Martin, Leila Kia, Neehar D. Parikh, Laura Kulik, Brandon McMahon
Ann Hepatol. 2014;13:548-54
Open access
Images in hepatology
Embolization of porto-systemic shunt as treatment for recurrent hepatic encephalopathy
Hugh Leonard, James O’Beirne, Dominic Yu, Emmanuel Tsochatzis
Ann Hepatol. 2014;13:555-7
Open access
Case report
Minimally invasive treatment of Mirizzi’s syndrome: is there a safe way? Report of a case series
Giuseppe Piccinni, Andrea Sciusco, Giuseppe Massimiliano De Luca, Angela Gurrado, Alessandro Pasculli, Mario Testini
Ann Hepatol. 2014;13:558-64
Open access
Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir
Vladimir Marquez-Azalgara, Trana Hussaini, Siegfried R. Erb, Eric M. Yoshida
Ann Hepatol. 2014;13:565-7
Open access
Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors
Serena Pelusi, Raffaela Rametta, Claudia Della Corte, Riccardo Congia, Paola Dongiovanni, Edoardo A. Pulixi, Silvia Fargion, Anna L. Fracanzani, ... Luca Valenti
Ann Hepatol. 2014;13:568-71
Open access
Letter to editor
Mean platelet volume: a useful predictor of ascitic fluid infection in cirrhotic patients?
Alpaslan Tanoglu, Ergenekon Karagöz
Ann Hepatol. 2014;13:572
Open access
Mean platelet volume is a useful indicator of systemic inflammation in cirrhotic patients with ascitic fluid infection
Burak Suvak, Serkan Torun, Adnan Tas, Yavuz Beyazit
Ann Hepatol. 2014;13:573
Open access
Liver news elsewhere
The good, the bad and the ugly of the new treatments for hepatitis C virus
Karen V. Silva-Vidal, Nahum Méndez-Sánchez
Ann Hepatol. 2014;13:574-5
Open access
Index section
Abstract section
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos